A review in the American Journal of Preventive Cardiology shows the PREVENT equation estimates ASCVD risk 30-50% lower than the Pooled Cohort Equation, potentially reducing statin eligibility and increasing missed cardiovascular events unless treatment thresholds change. Authors recommend using coronary artery calcium (CAC) scoring with PREVENT to better guide preventive therapy.